Results
|
301.
|
|
|
302.
|
|
|
303.
|
|
|
304.
|
|
|
305.
|
|
|
306.
|
|
|
307.
|
|
|
308.
|
|
|
309.
|
|
|
310.
|
|
|
311.
|
|
|
312.
|
|
|
313.
|
|
|
314.
|
|
|
315.
|
|
|
316.
|
|
|
317.
|
CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma. [electronic resource] by
- Kumai, Takumi
- Nagato, Toshihiro
- Kobayashi, Hiroya
- Komabayashi, Yuki
- Ueda, Seigo
- Kishibe, Kan
- Ohkuri, Takayuki
- Takahara, Miki
- Celis, Esteban
- Harabuchi, Yasuaki
Producer: 20150902
In:
Cancer immunology, immunotherapy : CII vol. 64
Availability: No items available.
|
|
318.
|
|
|
319.
|
|
|
320.
|
|